3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 1/2
1
Status
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
3
Genitourinary
2
Dermatologic
2
Thoracic
1
Other solid neoplasm
1
Other
1
Gynecologic
1
Breast
1
Conditions
Melanoma
1
Keratosis, Actinic
1
Keratosis
1
Interventions
pembrolizumab
69
Nivolumab
57
Ipilimumab
36
Specimen Handling
32
Magnetic Resonance Spectroscopy
25
Cyclophosphamide
22
Biopsy
18
cemiplimab
14
fludarabine
13
relatlimab
11
binimetinib
11
Opdualag
11
CTLA-4 Antigen
11
trametinib
10
fludarabine phosphate
10
Radiosurgery
10
avelumab
9
lifileucel
8
dabrafenib
8
Radiotherapy
8
atezolizumab
7
aldesleukin
7
Paclitaxel
7
Blood Specimen Collection
7
encorafenib
6
X-Rays
6
Standard of Care
6
Interleukin-2
6
Immunoglobulin G
6
HhAntag691
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Cryotherapy
×
Dermatologic
×
90 days
×
Clear all
NCT03949153
2026-06-05
CRIRIN
University Hospital, Strasbourg, France
Phase 1/2
Completed
19 enrolled
NCT07273656
2026-05-22
TIRBACRYO
University Hospital, Lille
Phase 3
Not yet recruiting
59 enrolled